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ABSTRACT 
Objective: Since 1979, the South African Institute for Medical 
Research (SAIMR) has served as the national reference center 
for pneumococcal serotyping and monitoring of antibiotic resis- 
tance trends. This study documents trends in antimicrobial 
resistance in pneumococci isolated from blood or cerebrospinal 
fluid (CSF) between 1991 and 1998 in South Africa. 
Methods: Pneumococcal isolates (n = 7406) from either blood 
or CSF were sent to the SAIMR reference laboratory for 
serotyping. The isolates were evaluated for resistance to peni- 
cillin, chloramphenicol, tetracycline, erythromycin, clindamycin, 
and rifampicin. 
Results: Resistance to one or more antibiotics increased sig- 
nificantly from 19% in 1991 to 1994 to 25% in 1995 to 1998 
in all ages, and in children from 32% to 38% (P < 10m6). 
Although penicillin resistance did not increase in children (28.1% 
vs. 28.9%), penicillin resistance in all ages increased from 9.6% 
to 18.0%. Significant increases in resistance to chlorampheni- 
col, tetracycline, ery-thromycin, and rifampicin also were seen 
in both groups. Multiple resistance increased significantly, from 
2.2% to 3.8%. The proportion of isolates with intermediate or 
high-level penicillin resistance remained constant during the 
surveillance period. Erythromycin resistance, predominantly 
expressed as simultaneous resistance to erythromycin and clin- 
damycin, increased from 1.6% to 2.6%. The percentage of 
erythromycin-resistant isolates that were resistance to et-y 
thromycin alone increased from 10.6% to 28.7%, suggesting 
the emergence of mefE-mediated resistance. In children 2 years 
of age and younger, although serogroup 6 remained the most 
common, there were significant increases in serogroups 19, 
18, and 13. The percentage of the total invasive pneumococcal 
disease in this population that is caused by serogroups found 
in the nonavalent pneumococcal conjugate vaccine (serogroups 
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1, 4, 5, 6B, 9V, 14, 18C 19F, 23F) increased from 72% to 
91%. 
Conclusions: Antibiotic resistance in the pneumococcus is 
increasing in South Africa, although the proportion of strains 
with high-level penicillin resistance has not increased. New con- 
jugate vaccines may not only decrease the burden of all pneu- 
mococcal disease but, in addition, lower the incidence of 
antibiotic-resistant disease in South Africa. 
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Streptococcuspneumoniae remains the leading cause of 
bacterial pneumonia and a significant cause of meningi- 
tis, bacteremia, and otitis media in young children, the 
elderly, and persons with underlying medical conditions, 
such as renal and liver failure, chronic pulmonary dis- 
ease, and diabetes mellitus.’ Pneumococcal disease also 
is a major cause of morbidity and mortality in persons 
infected with human immunodeficiency virus (HIV).2 
Treatment of pneumococcal disease is often empirical, 
with penicillin as the antibiotic of choice; however, the 
global spread of antibiotic-resistant pneumococci threat- 
ens to undermine current treatment recommendations. 
Documentation of penicillin resistance first appeared 
in 1967,‘; and there has been a rapid expansion of resis- 
tance in the pneumococcus in the past 5 years. l In South 
Africa, multiply resistant pneumococci were first recog- 
nized in 1977, prompting the establishment of a national 
survey for antimicrobial resistance. The first report of this 
survey covered the years 1979 to 1986,* and the update 
of surveillance included 1979 to 1990.5 The South African 
Institute for Medical Research (SAIMR) also serves as a 
national reference center for pneumococcal serotyping 
and monitoring of antibiotic resistance trends. This 
report, a follow-up to earlier reports, documents trends 
in antimicrobial resistance in pneumococci occurring 
between 1991 and 1998 in South Africa. 
MATERIALS AND METHODS 
Streptococcus pneumoniae isolates were sent to SAIMR 
either on 5% blood agar (plates or slopes) or, more 
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recently, on Dorset egg medium (slopes).’ The isolates 
were subcultured onto 5% blood agar plates and then 
confirmed to be pneumococci by colony morphology 
and susceptibility to optochin. Antimicrobial susceptibil- 
ity was determined on Mueller-Hinton media containing 
5% sheep blood, using Mastrings (Mast Diagnostics, 
Merseyside, England) with disks containing antibiotic 
concentrations specified by the National Committee for 
Laboratory Standards (NCCLS).’ Susceptibility was deter- 
mined to oxacillin to predict resistance to penicillin (P), 
chloramphenicol (C), tetracycline (T), erythromycin (E), 
clindamycin (Cd), and rifampicin (R).’ The minimum 
inhibitory concentrations (MICs) were determined using 
the microtitre method and cation-adjusted Mueller-Hinton 
broth supplemented with 2.5% lysed horse blood. The 
NCCLs breakpoints for intermediate resistance were 
@g/mL): penicillin (0.12-l.O), tetracycline (4), ery- 
thromycin (0.5) clindamycin (0.5) and rifampicin (2). 
There is no intermediate resistance level to chloram- 
phenicol.’ The breakpoints for high-level resistance were 
(kg/mL): penicillin (22) chloramphenicol (28) tetracy- 
cline (28), erythromycin (>l), clindamycin (21), and 
rifampicin (24). Capsular typing was done by the Aquel- 
lung technique, using antisera obtained from the Statens 
Seruminstitut (Copenhagen). 
Patient ages were not available for all of the speci- 
mens. In some instances, an age of less than 13 years was 
inferred by a hospital number indicating the patient had 
been admitted to a pediatric ward or if the hospital sub- 
mitting the specimen admitted only children. 
The data were entered into and analyzed using the 
Epi Info computer software package.8 
RESULTS 
Between 1991 and 19987406 pneumococci isolated 
from either blood or CSF were sent to the SAIMR labo- 
ratory. The laboratory confirmed antibiotic susceptibility 
Table 1. Antibiotic Resistance of Pneumococci Isolated 
from Blood and CSF from South Africa, 1991-l 998 
Number of kolates (%) 
7991-7994 1995-1998 
Children 
Antibiotic (n = 765) 
Penicillin 215 (28.1) 
Chloramphenicol 18 (2.4) 
Tetracycline 42 (5.5) 
Erythromycin 14 (1.8) 
Clindamycin 12 (1.6) 
Rifampin 4 (0.5) 
Any antibiotic 244 (32.0) 
A// Ages* 
(n = 3712) 
356 (9.6) 
44 (1.2) 
219 (5.9) 
58 (1.6) 
51 (1.4) 
10 (0.3) 
694 (18.7) 
Children 
(n = 1052) 
304 (28.9) 
53 (5.0)+ 
130 (12.4)+ 
44 (4.2)+ 
27 (2.6) 
18 (1.7)+ 
404 (38.4)+ 
A// Ages* 
(n = 3694) 
667 (18.1)+ 
90 (2.4)’ 
345 (9.3)+ 
98 (2.6)+ 
57 (1.5) 
31 (0.8)+ 
924 (25.0)+ 
*All ages includes those known to be children: tsignificant difference between 
1991-l 994 and 1995-I 998 (P < 0.05). 
or resistance for 3712 blood or CSF isolates between 
1991 and 1994 and for 3694 isolates from 1995 to 1998. 
Antibiotic resistance increased significantly over the 
surveillance period, from 18.7% in 1991 to 1994 to 25% 
in 1995 to 1998 in all ages, and in children from 32.0% 
to 38.4% (Table 1). For all ages and for children, signiti- 
cant increases occurred in resistance to chlommphenicol, 
tetracycline, erythromycin, and rifampicin. In all ages peni- 
cillin resistance increased from 9.6% to 18.1%. 
The patterns of antibiotic resistance are found in 
Table 2. Single resistance to penicillin rose from 10.4% to 
12.7% of isolates and resistance to erythromycin alone, 
which was not seen prior to 1995, increased to 0.1%. 
Larger increases occurred in simultaneous resistance to 
two or more antibiotics (see Table 2). Combinations of P 
+ C + T- and PTECd-resistance were most common. Con- 
current resistance to all six antimicrobials decreased sig- 
nificantly from 1994. Minimum inhibitory concentrations 
were determined for 638 resistant pneumococci isolated 
from 1991 to 1994 and for 855 resistant isolates received 
from 1995 to 1998. In the 8-year sampling period, the 
proportion of both intermediate and high-level resistance 
to all of the antibiotics remained constant. High-level 
Table 2. Antibiotic Resistance Patterns of Pneumococcal 
Isolates from Blood or CSF in South Africa, 1991-1998 
Number of isolates (%*) 
7991-1994 1995-7998 
Antibiotic (n = 3712) (n = 3694) 
Penicillin (P) 387 (10.40) 468 (12.70)+ 
Tetracyclin m 135 (3.60) 173 (4.70)+ 
Erythromycin (E) - 3 (0.10) 
Rifampin (R) 7 (0.20) 19 (0.50)+ 
P+T 19 (0.50) 31 (0.80) 
P+R 16 (0.40) 13 (0.35) 
P+C 2 (0.05) 4 (0.11) 
P+E 2 (0.05) 7 (0.20) 
P + clindamycin (Cd) - 2 (0.05) 
T+E 3 (0.10) 13 (0.35)+ 
T+R - 3 (0.10) 
C+T 9 (0.20)+ 
E + Cd l-(0.03) 3 (0.10) 
P+C+T 28 (0.75) 60 (1.60)+ 
P+E+Cd 5 (0.13) 11 (0.30) 
P+C+R 1 (0.03) 
P+T+E 4 (0.11) 5 (0.14) 
P+T+R 2 (0.05) 3 (0.10) 
T+E+Cd 37 (1 .OO) 23 (0.60) 
P+C+T+R 12 (0.32) 16 (0.40) 
P+T+E+Cd 8 (0.10) 34 (0.90)1 
P+C+T+E 7 (0.20)+ 
C+T+E+Cd 3 -(o.ol) 1 (0.03) 
T+E+Cd+R 1 (0.03) 1 (0.03) 
P+C+T+E+Cd 4 (0.11) 12 (0.30)+ 
P+C+T+E+R 1 (0.03) 
P+T+E+Cd+R 2 (0.05) 
P+C+T+E+Cd+R 17 -(0.46)+ 
Pan-susceptible 3018 (81.30)+ 2770 (f5.00) 
Multiply resistantt 80 (2.20) 140 (3.80) 
*Percentages may not total 100% due to rounding; tsignificant difference 
between 1991-1994 and 1995-1998 (P S 0.05): *resistant to three different 
classes of antibiotics. 
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resistance to penicillin was found in 8% and 10% of the 
isolates from 1991 to 1994 and 1995 to 1998, respectively. 
In contrast, more than 94% of the resistance to the other 
antibiotics was high-level resistance. A sample of 56 peni- 
cillin resistant isolates from 1991 to 1994 and 46 isolates 
from 1995 to 1998 also were tested for resistance to cef- 
triaxone; intermediate resistance was found in one isolate 
from each time interval (1.8% and 2.2%, respectively). 
The distribution of serogroups from children 2 years 
of age and younger is found in Table 3. Serogroup 6 
remained the most common, followed by group 19, which 
increased significantly since 199 1, and then groups 1 and 
14. Significant changes in prevalence also were seen for 
serogroups 18 and 13. The percentage of the total inva- 
sive pneumococcal disease in this population that is 
caused by serogroups found in the pneumococcal con- 
jugate vaccine containing serogroups or types 1,4,5, GB, 
9V, 14,1X, 19F, 23F increased from 72% to 91%. 
DISCUSSION 
The trend in antibiotic resistance from 1982 to 1998 is 
shown in Figure 1. Previous surveys of pneumococcal 
antibiotic resistance in South Africa documented 
increases in resistance to any antibiotic from 6% in 1979 
to 1982 to 10% in the period 1983 to 1986.5 Resistance 
to penicillin increased from 4.9% to 14.4% between 1979 
Table 3. Serotypes or Groups of Pneumococci 
Isolated from Blood or CSF of South African 
Children 2 Years of Age and Younger, 1991-1998 
1991-1994 19951998 
Number Number 
(%) of (%) of 
Serogroup lsolafes lsolafes 
or serotype (n = 506) Rank (n = 257) Rank 
1 57 (11.3) 3 34 (13.2)* 3 
2 4 (0.8) 13 - 
3 2 (0.8)+ 13 
4 13 (2.6) 10 9 (3.5)* 6 
5 14 (2.8) 7 7 (2.7)* 7 
6 184 (36.4) 1 86 (33.5)* 1 
7 19 (3.7) 5 (1.9) 9 
8 7 (1.4) 1: 5 (1.9) 9 
9 10 (2.0) 1 7 (2.7)* 7 
IO 4 (0.8) 13 3 (1.2) 12 
11 1 (0.2) 16 1 (0.4) 15 
12 3 (0.6) 15 
13 - 4 ;1.5)+ 11 
14 85 (T6.8) 2 31 (12.1)* 4 
15 14 (2.8) 1: 2 (0.8) 13 
16 1 (0.2) - 
18 17 (3.3) 6 1 (0.4)*+ 15 
19 56(11.1) 47 (18.3)*+ 2 
20 1 (0.2) 1: - 
23 
28 
14 (2.8) 1: 12 (4.7)* 5 
1 (0.2) - - 
29 1 (0.2) 16 - - 
34 - 1 (0.4) - 
*Serotypes found ~nthe nonavalent conjugatevaccine; tsignlficantdifference 
between 1991-1994 and 1995-l 998 (P 5 0.05). 
and 1990.6 Multiply resistant strains, resistant to three or 
more classes of antibiotics, accounted for 1.6% of the 
total number of isolates tested between 1979 and 1986.5 
In comparison, the present study found one-quarter of 
the isolates sent to the SAIMR between 1995 and 1998 
to be resistant to at least one antimicrobial, and it found 
penicillin resistance in almost 20% of the isolates. The 
proportion of both intermediate and high-level resistance 
to penicillin did not change significantly, and high-level 
resistance remains less than 10% of the total penicillin 
resistance. Over 95% of the resistance to tetracycline is 
high level, whereas resistance to rifampicin, chloram- 
phenicol, erythromycin, and clindamycin remains below 
5%. The current study also found a rise in the number of 
multiply resistant pneumococci from 2% to 4%, although 
since 1995 there have been no isolates sent to the SAIMR 
that are resistant to all six antibiotics tested. Surveillance 
for resistance to the fluoroquinolones was begun in 1999. 
Antibiotic resistance in children is usually higher than 
in the group of all ages with pneumococcal disease 
because the common serogroups causing disease in chil- 
dren (serogroups 6, 14, 19, and 23) are more likely to be 
antibiotic-resistant. In this study, resistance to any anti- 
biotic in children increased significantly from 32% to 
38.4%; penicillin resistance remained constant at approx- 
imately 29%. In contrast, a study conducted in 1998 in the 
private sector in northern Johannesburg found overall 
resistance rates of 69% and 45.4% of the isolates resistant 
to penicillin.9 The discrepancy between antibiotic resis- 
tance in the public and private sector is likely a reflection 
of the availability and use of antibiotics in children attend- 
ing private practitioners. The serogroup distribution in 
young children remained fairly stable over the 7 years of 
the study, although there was a statistically significant 
increase in isolation of serogroup 19, again a serogroup 
commonly associated with antibiotic resistance. 
A limitation to this study was the lack of patient ages 
for all of the isolates, which would have allowed separate 
analyses of antibiotic resistance in adults and in children. 
20 
18 
z 16 
g 14 / 
1979-82 1983-86 1987-90 1991-94 1995-98 
Period (y) 
Figure 1 Trend in antibiotic resistance from 1982 to 1998 in South 
Africa. 
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Specimens are often submitted to hospital laboratories 
without complete patient demographic information; 
therefore, no ages were available when the resulting iso- 
lates were referred to the SAIMR. 
Infection with HIV is increasing in South Africa, and 
as many as 23% of adults and 36% of children admitted 
to Chris Hani Baragwanath Hospital in Soweto are 
infected with the virus.‘” A retrospective study of pneu- 
mococci isolated from blood between 1993 and 1995 
found that HIV-infected patients were more likely to have 
penicillin-resistant organisms than their HIV-uninfected 
counterparts (29.7% vs. 8.6%).‘” Serotype 14 and sero- 
group 6, pneumococcal strains more commonly found in 
children and frequently associated with antibiotic resis- 
tance, also were significantly increased in HIV-infected 
adults. The changing pattern of pneumococcal disease 
resulting from HIV infection also could mean an increase 
in antibiotic resistance in South Africa. Surprisingly, 
although tuberculosis also is increasing in South Africa, 
rifampicin resistance in the pneumococcus remains low. 
This study describes one country experiencing 
increases in antibiotic resistance in the pneumococcus. 
In 1992 in an overview of pneumococcal resistance, 
Appelbaum described surveys of pneumococcal resis- 
tance from 25 countries on six continents.” Penicillin- 
resistant organisms were isolated in every survey, and 
resistance rates of 10% or less were found in 13 countries. 
Resistant pneumococci were prevalent in Europe, par- 
ticularly Spain, France, and Hungary, as well as in Israel 
and the United States. In the United States, 33.5% of 9190 
isolates collected over a d-month period in 1996 to 1997 
were resistant to penicillin.” In Spain, trends in penicillin 
resistance are similar to those in South Africa. One study 
from Spain examining pneumococci isolated from 
patients between 1979 and 1989 found an overall resis- 
tance rate of 65.5% and an increase in penicillin resis- 
tance from 6% at the start of the survey to 44% in I989.‘> 
Pneumococcal penicillin resistance can be spread either 
through dissemination of resistant clones or by the trans- 
fer of resistance genes, those coding for penicillin-bind- 
ing proteins (PBPs), between different pneumococci. 
Examination of the DNA sequences of PBPs from 27 
pneumococcal isolates from South Africa identified three 
clones circulating within the country.‘” Two of the clones 
of serotypes 19A and 6B were penicillin-resistant and the 
third was a serotype 19A that was resistant to penicillin, 
chloramphenicol, tetracycline, erythromycin, clindamycin, 
and rifampicin. These clones were isolated from geo- 
graphically distant areas of South Africa. Analysis of 328 
isolates in the United States suggests that the explosion 
of penicillin resistance to almost 40% in that country is 
at least partially attributable to the importation and clonal 
expansion of two highly resistant international clones, 
the “Spanish” 23F clone and the “French” serogroup 9 or 
14 clone. I5 Interestingly, a multiply resistant serotype 23~ 
pneumococcus originating in Spain was isolated in 1991 
from the throat of a 3-year old South African child with 
otitis media.‘” Epidemiologic investigations found that 
the strain likely was imported into South Africa by the 
child’s aunt who had lived in Spain for a year. That par- 
ticular strain also was isolated from the nasopharynx of 
six other persons, including the index child’s mother and 
sibling, and two classmates and their siblings. Despite the 
early importation of that clone, it does not appear to have 
gained the stronghold it has gained in the United States. 
The background level of intermediate penicillin resis- 
tance in pneumococci in South Africa may be excluding 
the “foreign” clones from occupying the ecologic niche 
required for them to establish as the dominant resistant 
strains. It is, however, more likely that differences in anti- 
biotic prescribing patterns may explain the lesser selec- 
tive advantage of the multiresistant 23F clone in South 
Africa. Data from Sweden have shown that macrolides 
and broad-spectrum p-lactams are more effective selec- 
tors of penicillin-resistant pneumococci than are the oral 
penicillins.‘- The low level of macrolide selection in the 
public sector in South Africa may have been critical in the 
slow rate of emergence of this strain. In keeping with 
this explanation, erythromycin resistance remains low 
(< 5%). It was primarily expressed as simultaneous resis- 
tance to both erythromycin and clindamycin. Such a resis- 
tance pattern is associated with the ermAM gene, which 
reduces the affinity between the antibiotic and the ribo- 
some.‘* The increasing percentage of erythromycin-resis- 
tant strains that do not show simultaneous resistance to 
clindamycin, however, suggests the emergence of the 
rnefi gene in South Africa, a gene that affects the efflux 
of the antibiotic from the cell.‘” Most erythromycin resis- 
tance in the United States is attributable to the mef E gene. 
What are the implications of the global emergence of 
antibiotic resistance in the pneumococcus? The use of peni- 
cillin for the empirical treatment of pneumonia may be 
unaffected by penicillin resistance up to a MIC of 4 g/mL. 
Several studies have shown that the mortality of children 
hospitalized with pneumococcal pneumonia and treated 
with p-lactam antibiotics does not differ depending on 
the resistance status of the organism.“‘.*’ The achievable 
blood and lung tissue levels of p-lactam antibiotics sur- 
pass the MICs of the pneumococci even at high levels of 
penicillin resistance. In contrast, antibiotic penetration 
into other tissues is less efficient, making penicillin resis- 
tance (intermediate or high-level) a major determinant 
in the choice of treatment for pneumococcal meningitis 
and, to a lesser extent, otitis media and sinusitis.l’,*” Data 
from the present study suggest that, in South Africa and 
possibly in many other African countries, access to the 
extended-spectrum cephalosporins, cefotaxime and cef- 
triaxone, is essential for the management of pneumo- 
coccal meningitis. Therefore, surveillance for antibiotic 
resistance is necessary, to ensure the successful manage- 
ment of pneumococcal meningitis, otitis media, and sinusi- 
tis. The antibiotic resistance patterns of S. pneumoniae 
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carried asymptomatically in the nasopharynx of children 
mirror the resistance rates of clinical isolates that cause 
invasive pneumococcal disease. 1~24,25 Carriage studies 
could serve as a useful alternative for monitoring anti- 
biotic resistance in countries where isolation of clinical 
strains is not feasible. 
All of the antibiotic-resistant pneumococcal isolates 
in this study were of serogroups found in a nonavalent 
conjugate vaccine. Vaccination may reduce the problem 
of antibiotic resistance in the pneumococcus. This vac- 
cine, comprised of serogroups or types 1,4,5, GB, 9V, 14, 
1X, 19F, and 23F, has been shown to significantly reduce 
carriage of vaccine-serotypes by 50% and carriage of peni- 
cillin-resistant serotypes by 49%.26 The success of this 
vaccine could not only substantially decrease the burden 
of all pneumococcal disease but also lower the incidence 
of antibiotic-resistant disease in South Africa. 
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